Skip to main content
. Author manuscript; available in PMC: 2010 Mar 17.
Published in final edited form as: Circulation. 2009 Mar 2;119(10):1386–1397. doi: 10.1161/CIRCULATIONAHA.108.802918

Table.

LV Hemodynamics in WT, TNFR1−/−, and TNFR2−/− Sham and HF Mice

WT TNFR1−/− TNFR2−/−
Sham (n = 15) HF (n = 21) Sham (n = 7) HF (n = 11) Sham (n = 8) HF (n = 15)
HR 539 ± 50 431 ± 49* 519 ± 36 511 ± 47# 530 ± 35 475 ± 53*#
LVPSP 98 ± 8 86 ± 8* 99 ± 10 96 ± 8# 98 ± 12 84 ± 5*^
dP/dtmax 10245 ± 2054 4962 ± 1346* 9328 ± 2084 7167 ± 1426*# 9611 ± 1659 4997 ± 993*^
dP/dtmax/IP 185 ± 35 98 ± 22* 165 ± 29 118 ± 19*# 170 ± 34 101 ± 22*^
LVEDP 8 ± 3 16 ± 4* 7 ± 1 12 ± 4*# 9 ± 3$ 8 ± 4#^
Tau 9.1 ± 2.1 18.8 ± 3.6* 10.4 ± 2.9 14.0 ± 2.3*# 10.4 ± 1.8 15.2 ± 2.8*#

LV, left ventricular; HR, heart rate (bpm); LVPSP, LV peak systolic pressure (mm Hg); dP/dtmax, maximal rate of change in LV pressure (mm Hg/s); dP/dtmax/IP, dP/dtmax normalized fro instantaneous LV pressure (s−1); LVEDP, LV end-diastolic pressure (mm Hg); tau, time constant of LV relaxation (ms); All values mean ± SD.

*

p < 0.05 vs. respective sham,

$

p < 0.05 vs. TNFR1−/− sham,

#

p < 0.05 versus WT HF,

^

p < 0.05 vs. TNFR1−/− HF.